Interestingly, the concurrent presence of amyloid, tau, and neurodegeneration pathologies—collectively referred to as the ATN (Amyloid-Tau-Neurodegeneration) triad—seems to intensify microglial activation [37,38]. The gene discussed is MAPT; the disease is amyloidosis.